Literature DB >> 2419197

Molecular basis for mustard-induced vesication.

B Papirmeister, C L Gross, H L Meier, J P Petrali, J B Johnson.   

Abstract

A biochemical hypothesis explaining the generation of pathology in human skin by mustard gas (HD) is presented which links the initiation of DNA damages to local alterations of metabolism and subsequent development of blisters. The proposed sequence involves HD alkylation of purines in DNA which are processed to form apurinic sites. Apurinic endonucleases act at these sites to produce backbone breaks in DNA which cause activation of the chromosomal enzyme poly(ADP-ribose)polymerase. This enzyme utilizes NAD+ as a substrate and, at vesicating doses of HD, would deplete the cells of their NAD+ content. The depletion in NAD+ would cause inhibition of glycolysis, and the resulting accumulation of common intermediates would stimulate the NADP+-dependent hexosemonophosphate shunt (HMS). Such stimulation of the HMS has been associated with DNA damage and enhancement of protease synthesis and release. These proteases could be responsible for development of subepidermal blisters which result from fluid accumulation in the cavity created by separation of the moribund basal cell layer from the basement membrane--a characteristic feature of HD-exposed human skin. Partial validation of this biochemical hypothesis has been achieved. DNA alkylated with either monofunctional or bifunctional sulfur mustards, followed by spontaneous or enzymatic depurination, was shown to be sensitized to degradation by apurinic endonuclease. Studies on the effect of HD on human skin grafted to athymic nude mice demonstrated dose- and time-related decreases in NAD+ levels. These decreases in NAD+ levels preceded and correlated to the predicted severity of pathology. The participation of poly(ADP-ribose)polymerase activity in the HD-induced NAD+ loss was substantiated by prevention of this loss in the presence of inhibitors of the enzyme. Additional supporting evidence for the proposed mechanism was obtained at the cellular level by studies which utilized human leukocytes. The subsequent involvement of the HMS and proteases in HD-induced vesication is discussed.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2419197

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  47 in total

Review 1.  Cellular and molecular mechanisms of sulfur mustard toxicity on spermatozoa and male fertility.

Authors:  Asghar Beigi Harchegani; Mahdiyeh Mirnam Niha; Milad Sohrabiyan; Mahdi Ghatrehsamani; Eisa Tahmasbpour; Alireza Shahriary
Journal:  Toxicol Res (Camb)       Date:  2018-07-09       Impact factor: 3.524

2.  Doxycycline hydrogels as a potential therapy for ocular vesicant injury.

Authors:  Marion K Gordon; Andrea Desantis; Manjeet Deshmukh; Carl Jeffrey Lacey; Rita A Hahn; John Beloni; Sivanaga S Anumolu; John J Schlager; Michael A Gallo; Donald R Gerecke; Ned D Heindel; Kathy K H Svoboda; Michael C Babin; Patrick J Sinko
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671

3.  Inhibition of sulfur mustard-increased protease activity by niacinamide, N-acetyl-L-cysteine or dexamethasone.

Authors:  F M Cowan; C A Broomfield; W J Smith
Journal:  Cell Biol Toxicol       Date:  1992 Apr-Jun       Impact factor: 6.691

4.  Sulfur mustard gas exposure: case report and review of the literature.

Authors:  J Goverman; R Montecino; A Ibrahim; K A Sarhane; R G Tompkins; S P Fagan
Journal:  Ann Burns Fire Disasters       Date:  2014-09-30

5.  Sulfur mustard-increased proteolysis following in vitro and in vivo exposures.

Authors:  F M Cowan; J J Yourick; C G Hurst; C A Broomfield; W J Smith
Journal:  Cell Biol Toxicol       Date:  1993 Jul-Sep       Impact factor: 6.691

6.  Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard.

Authors:  C L Gross; J K Innace; R C Hovatter; H L Meier; W J Smith
Journal:  Cell Biol Toxicol       Date:  1993 Jul-Sep       Impact factor: 6.691

7.  Catalytic antioxidant AEOL 10150 treatment ameliorates sulfur mustard analog 2-chloroethyl ethyl sulfide-associated cutaneous toxic effects.

Authors:  Neera Tewari-Singh; Swetha Inturi; Anil K Jain; Chapla Agarwal; David J Orlicky; Carl W White; Rajesh Agarwal; Brian J Day
Journal:  Free Radic Biol Med       Date:  2014-05-09       Impact factor: 7.376

8.  Topical nitrogen mustard exposure causes systemic toxic effects in mice.

Authors:  Dinesh G Goswami; Dileep Kumar; Neera Tewari-Singh; David J Orlicky; Anil K Jain; Rama Kant; Raymond C Rancourt; Deepanshi Dhar; Swetha Inturi; Chapla Agarwal; Carl W White; Rajesh Agarwal
Journal:  Exp Toxicol Pathol       Date:  2014-12-04

9.  Gene expressions in Jurkat cells poisoned by a sulphur mustard vesicant and the induction of apoptosis.

Authors:  Peng Zhang; Patrick Ng; Diana Caridha; Richard A Leach; Ludmila V Asher; Mark J Novak; William J Smith; Steven L Zeichner; Peter K Chiang
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 10.  Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure.

Authors:  Michael P Shakarjian; Diane E Heck; Joshua P Gray; Patrick J Sinko; Marion K Gordon; Robert P Casillas; Ned D Heindel; Donald R Gerecke; Debra L Laskin; Jeffrey D Laskin
Journal:  Toxicol Sci       Date:  2009-10-15       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.